Beyond Cure

Evolving Care Models

Australia faces a mounting crisis in managing progressive neurodegenerative diseases such as Parkinson's, dementia, and multiple sclerosis, where cures remain elusive. Recent developments, including a $3.7 million funding injection from the Medical Research Future Fund and community contributions, have enabled the rollout of ParkinsonNet. This initiative, adapted from a successful Dutch framework, connects patients to allied health professionals via online platforms, emphasizing collaborative care to maintain dignity and capability.

The timing aligns with demographic shifts: Australia's population is aging rapidly, with projections indicating over 6.4 million dementia diagnoses in the next 40 years if breakthroughs lag. Prevalence of multiple sclerosis hit 37,756 in 2024, up 47.7% since 2017, while Parkinson's affects 220,000 individuals. These statistics underscore the shift needed from traditional curative focuses to holistic approaches that incorporate digital innovations and multidisciplinary teams.

Economic pressures amplify the urgency. Brain disorders impose a $74 billion annual burden, with neurological conditions alone accounting for $31 billion. Per-person costs for Parkinson's reach $32,556 to the health system and $45,000 to society, escalating fourfold with disease severity. Multiple sclerosis tallies $3 billion yearly, driven by productivity losses and informal care. Without intervention, these figures could balloon to $7.51 billion for motor neurone disease alone by 2050.

July 2025 Medicare reforms streamline chronic disease management, replacing separate plans with a unified GP Chronic Condition Management Plan. This encourages quarterly reviews and flexible allied health access, potentially curbing unnecessary hospital stays. Yet, deadlines loom: ParkinsonNet's pilot runs through 2030, aiming for a national roadmap, while the Australian Centre for Disease Control, established in 2025, eyes expansion into chronic conditions by 2028.

Non-obvious tensions emerge in this transition. Prioritizing palliative over curative care can yield cost savings—integrated models reduce hospitalisations by improving symptom management—but demands a cultural shift in medicine, where fee-for-service incentives favor procedures. Digital tools like ParkinsonNet risk exacerbating inequities for rural or tech-limited populations, despite aims for equitable access. Stakeholder frictions arise too: governments balance funding amid competing priorities, while GPs navigate ethical dilemmas in ceasing life-extending treatments for palliative patients.